Form 4: Amarin Director Louis Sterling III Receives Stock Options and Restricted Stock Units
SEC Form 4
Director Louis Sterling III was granted stock options and restricted stock units (RSUs) following Amarin's annual general meeting.
Summary
- On April 18, 2024, Louis Sterling III, a director of Amarin, received stock options and restricted stock units (RSUs).
- The stock options grant is for 179,795 ordinary shares with an exercise price of $0.87.
- These options vest over three years, with 33% vesting on the first anniversary and the remaining balance vesting in equal quarterly installments.
- Sterling also received 50,287 RSUs, which vest in three equal installments on April 18, 2025, April 18, 2026, and April 18, 2027.
- Each RSU represents a contingent right to receive one ordinary share or cash at Amarin's discretion.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard compensation practices and aligns management interests with shareholders.
Positives
- The grant of stock options and RSUs aligns the director's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the director.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedules of the options and RSUs.
Industry Context
Grants of stock options and RSUs are common practices in the pharmaceutical industry to incentivize and retain key personnel.
Comparison to Industry Standards
- Stock option and RSU grants are a standard component of executive compensation packages in the pharmaceutical industry.
- Companies like Pfizer, Johnson & Johnson, and Novartis also use similar equity-based compensation plans to align executive interests with shareholder value.
- The vesting schedules described are typical, with three-year vesting periods being common.
Stakeholder Impact
- Shareholders may view the grants positively as they incentivize the director to work towards increasing shareholder value.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 04/18/2024 | Date of transaction: Grant of stock options and RSUs. |
| 04/18/2025 | First vesting date for RSUs (one-third of total). |
| 04/18/2026 | Second vesting date for RSUs (one-third of total). |
| 04/18/2027 | Final vesting date for RSUs (one-third of total). |
| 04/18/2034 | Expiration date for the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.